In the face of rising costs and an increasingly tight regulatory
environment, leading healthcare organizations are looking for ways
to more efficiently manage spend and risk while driving compliance.
And an increasing number are turning to Ariba, Inc. (Nasdaq: ARBA),
the leading provider of collaborative business commerce solutions,
for help. The company today announced that it has signed a new
agreement with Dana-Farber Cancer Institute, an affiliate of
Harvard Medical School whose mission is to provide expert,
compassionate care to children and adults with cancer while
advancing the understanding, diagnosis, treatment, cure, and
prevention of cancer and related diseases. Under the terms of the
agreement, Dana-Farber will utilize Ariba® Contract Management™ to
gain greater visibility into and control over its spend and fuel
greater compliance with its contracting process.
“Dana-Farber must negotiate contracts that represent the best
value for our organization and ensure compliance with them,” said
John Willi, Director of Materials Management, Dana-Farber. “Ariba
Contract Management provides us with the technology and processes
we need to do this quickly and delivers them in a flexible and
cost-effective manner.”
Complex Problems Easily Solved
Delivered on-demand through the Ariba Commerce Cloud, Ariba
Contract Management delivers market-leading technology in a fully
hosted environment with data security standards that exceed those
of any enterprise company.
Ariba Contract Management helps legal, finance, procurement, and
sales operations professionals manage all types of agreements,
including supplier (buy), customer (sell), and internal contracts
and is used by companies around the world to manage more than four
million contracts each day. Ariba Contract Management enables
companies to develop best-value agreements by delivering all of the
tools needed to address the two major components of the contract
lifecycle:
Contract Management:
- Contract authoring tools including
clause libraries and conditional templates
- Microsoft Word integration
- Contracting process standardization
incorporating workflows and approvals
- Audit trail for internal and
external/regulatory requirements
Commitment Management
- Reminders and search and reporting
capabilities as well as contract renewal activities
- Centralized electronic contract
repository
- Search and reporting capabilities
- Task-driven notification alerts
- Expiry notification for improved
renewal management
- Improved relationships resulting in
more up-sell opportunities
“With Ariba Contract Management, Dana-Farber can connect
directly with its trading partners when creating, negotiating,
executing, and managing contracts across its organization,” said
Steve Markle, Senior Director, Solutions Management, Ariba. “And
this means not only finding all of their contracts for greater
visibility into what it’s spending with whom, but improved
relationships that result in higher-value agreements against which
it can drive compliance.”
Dana-Farber joins more than 80 organizations across the global
healthcare industry who use Ariba’s solutions to manage their
commerce activities, including: the American Cancer Society,
AstraZeneca, Bristol-Myers Squibb Company, Five Star Quality Care,
Inc., Genzyme Corporation, GlaxoSmithKline, Hoffmann-La Roche Inc.,
Janssen Pharmaceutical & Research Foundation, Medtronic, Inc.,
Merck & Co., Inc., Novartis AG, Pfizer Inc., Ranbaxy
Laboratories Limited, Roche Diagnostics Corporation, Roche
Pharmaceuticals, Sanofi-Aventis, West Penn Allegheny Health System
and many others.
To learn more about Ariba’s solutions and the value they
deliver, visit www.ariba.com
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute (www.dana-farber.org) is a
principal teaching affiliate of the Harvard Medical School and is
among the leading cancer research and care centers in the United
States. It is a founding member of the Dana-Farber/Harvard Cancer
Center (DF/HCC), designated a comprehensive cancer center by the
National Cancer Institute. It provides adult cancer care with
Brigham and Women's Hospital as Dana-Farber/Brigham and Women’s
Cancer Center and it provides pediatric care with Children's
Hospital Boston as Dana-Farber/Children’s Hospital Cancer Center.
Dana-Farber is the top ranked cancer center in New England,
according to U.S. News & World Report, and one of the largest
recipients among independent hospitals of National Cancer Institute
and National Institutes of Health grant funding.
About Ariba, Inc.
Ariba, Inc. is the leading provider of collaborative business
commerce solutions. Ariba combines industry-leading technology to
optimize the complete commerce lifecycle with the world's largest
web-based community to discover, connect and collaborate with a
global network of trading partners, delivering everything needed to
control costs, minimize risk, improve profits and enhance cash flow
and operations – all in a cloud-based environment. Whether you’re
buying, selling or managing cash, you can do it more efficiently
and effectively in the Ariba® Commerce Cloud. Over 325,000
companies, including more than 90 percent of the Fortune 100, use
Ariba’s solutions to drive more efficient inter-enterprise
commerce. Why not join them? For more information on Ariba commerce
solutions and the results they deliver, visit www.ariba.com
Copyright © 1996 – 2010 Ariba, Inc.
Ariba, the Ariba logo, AribaLIVE, Ariba.com, Ariba.com Network,
Ariba Spend Management. Find it. Get it. Keep it. and PO-Flip are
registered trademarks of Ariba, Inc. Ariba Procure-to-Pay, Ariba
Buyer, Ariba eForms, Ariba PunchOut, Ariba Services Procurement,
Ariba Travel and Expense, Ariba Procure-to-Order, Ariba Procurement
Content, Ariba Sourcing, Ariba Savings and Pipeline Tracking, Ariba
Category Management, Ariba Category Playbooks, Ariba StartSourcing,
Ariba Spend Visibility, Ariba Analysis, Ariba Data Enrichment,
Ariba Contract Management, Ariba Contract Compliance, Ariba
Electronic Signatures, Ariba StartContracts, Ariba Invoice
Management, Ariba Payment Management, Ariba Working Capital
Management, Ariba Settlement, Ariba Supplier Information and
Performance Management, Ariba Supplier Information Management,
Ariba Discovery, Ariba Invoice Automation, Ariba PO Automation,
Ariba Express Content, Ariba Ready, and Ariba LIVE are trademarks
or service marks of Ariba, Inc. All other brand or product names
may be trademarks or registered trademarks of their respective
companies or organizations in the United States and/or other
countries.
Ariba Safe Harbor
Safe Harbor Statement under the Private Securities Litigation
Reform Act 1995: Information and announcements in this release
involve Ariba's expectations, beliefs, hopes, plans, intentions or
strategies regarding the future and are forward-looking statements
that involve risks and uncertainties. All forward-looking
statements included in this release are based upon information
available to Ariba as of the date of the release, and we assume no
obligation to update any such forward-looking statements. These
statements are not guarantees of future performance and actual
results could differ materially from our current expectations.
Factors that could cause or contribute to Ariba's operating and
financial results to differ materially from current expectations
include, but are not limited to: the impact of the credit crises on
Ariba’s results of operations and financial condition; delays in
development or shipment of new versions of Ariba's products and
services; lack of market acceptance of Ariba's existing or future
products or services; inability to continue to develop competitive
new products and services on a timely basis; introduction of new
products or services by major competitors; the impact of any
acquisitions, including risks and uncertainties arising from the
possibility that a closing may be delayed or may not occur and
difficulties with the integration process or the realization of
benefits of a transaction; the impact of our disposition, including
the potential disruption of our ongoing business; the ability to
attract and retain qualified employees; difficulties in
assimilating acquired companies, long and unpredictable sales
cycles and the deferrals of anticipated orders; declining economic
conditions, including the impact of a recession; inability to
control costs; changes in the company's pricing or compensation
policies; significant fluctuations in our stock price; the outcome
of and costs associated with pending or potential future regulatory
or legal proceedings; the impact of our acquisitions and
dispositions, including the disruption or loss of customer,
business partner, supplier or employee relationships; and the level
of costs and expenses incurred by Ariba as a result of such
transactions. Factors and risks associated with its business,
including a number of the factors and risks described above, are
discussed in Ariba's Form 10-K filed with the SEC on November 23,
2010.
Ariba (NASDAQ:ARBA)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Ariba (NASDAQ:ARBA)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
